Publicacions en què col·labora amb Beatriz García Fernández (12)

2021

  1. The genes encoding small leucine-rich proteoglycans undergo differential expression alterations in colorectal cancer, depending on tumor location

    Cells, Vol. 10, Núm. 8

2020

  1. Heparan sulfate proteoglycans undergo differential expression alterations in alzheimer disease brains

    Journal of Neuropathology and Experimental Neurology, Vol. 79, Núm. 5, pp. 474-483

2019

  1. Chondroitin Sulfate in Human Cutaneous Meissner and Pacinian Sensory Corpuscles

    Anatomical Record, Vol. 302, Núm. 2, pp. 325-331

  2. Class I and Class II small leucine-rich proteoglycans in human cutaneous pacinian corpuscles

    Annals of Anatomy, Vol. 224, pp. 62-72

2018

  1. Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character

    BMC Cancer, Vol. 18, Núm. 1

2017

  1. Heparanase Overexpresses in Keratoconic Cornea and Tears Depending on the Pathologic Grade

    Disease Markers, Vol. 2017

  2. Merkel cells and Meissner's corpuscles in human digital skin display Piezo2 immunoreactivity

    Journal of Anatomy, Vol. 231, Núm. 6, pp. 978-989

  3. Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 58, Núm. 1, pp. 185-192

2016

  1. Different use of cell surface glycosaminoglycans as adherence receptors to corneal cells by gram positive and gram negative pathogens

    Frontiers in Cellular and Infection Microbiology, Vol. 6, Núm. NOV

  2. Differential expression of proteoglycans by corneal stromal cells in keratoconus

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 6, pp. 2618-2628

  3. Heparanase and heparanase 2 display differently deregulation in neuroendocrine tumors, depending on their differentiation grade

    Histology and Histopathology, Vol. 31, Núm. 1, pp. 73-81

2014

  1. Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade

    Frontiers in Oncology, Vol. 4 FEB